Brian Allen Carrico net worth and biography

Brian Carrico Biography and Net Worth

CEO of NeurAxis

Brian Carrico is the President and Chief Executive Officer of NeurAxis, Inc. Brian also serves as a Director on the Board for NeurAxis. He joined NeurAxis in 2012, and during his tenure at NeurAxis, Brian has held multiple leadership positions of increasing responsibility, including Vice President of Sales and President before becoming CEO on January 1, 2018. As an early employee in the Company's life cycle, Brian was instrumental in setting the strategic agenda for NeurAxis, raising start-up capital, championing new product development, and bringing the Company’s technology to market. Prior to joining NeurAxis, Brian worked selling in the operating room at Bard Medical and in the Cath lab at St. Jude Medical. He attended Indiana State University and holds a Bachelor of Science in Business Marketing.

What is Brian Allen Carrico's net worth?: The estimated net worth of Brian Allen Carrico is at least $2.57 million as of April 1st, 2026. Carrico owns 348,178 shares of NeurAxis stock worth more than $2,573,035 as of September 16th. This net worth evaluation does not reflect any other assets that Carrico may own. Learn More about Brian Allen Carrico's net worth.
How do I contact Brian Allen Carrico?: The corporate mailing address for Carrico and other NeurAxis executives is 11611 N. Meridian ST, Suite 330, Carmel, IN, 46032. NeurAxis can also be reached via phone at (812) 689-0791 and via email at [email protected]. Learn More on Brian Allen Carrico's contact information.
Has Brian Allen Carrico been buying or selling shares of NeurAxis?: Brian Allen Carrico has not been actively trading shares of NeurAxis in the last ninety days. Most recently, on Wednesday, April 1st, Brian Allen Carrico bought 8,060 shares of NeurAxis stock. The stock was acquired at an average cost of $1.96 per share, with a total value of $15,797.60. Following the completion of the transaction, the chief executive officer now directly owns 348,178 shares of the company's stock, valued at $682,428.88. Learn More on Brian Allen Carrico's trading history.
Are insiders buying or selling shares of NeurAxis?: During the last twelve months, NeurAxis insiders bought shares 4 times. They purchased a total of 302,458 shares worth more than $1,039,192.96. The most recent insider tranaction occured on April, 1st when CFO Timothy Robert Henrichs bought 7,593 shares worth more than $14,882.28. Insiders at NeurAxis own 21.1% of the company. Learn More about insider trades at NeurAxis.
Information on this page was last updated on 4/1/2026.

Brian Allen Carrico Insider Trading History at NeurAxis

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
4/1/2026	Buy	8,060	$1.96	$15,797.60	348,178

Brian Allen Carrico Buying and Selling Activity at NeurAxis

NeurAxis Company Overview

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.

Today's Range

Now: $7.20

$6.14

$7.74

50 Day Range

MA: $6.41

$5.69

$7.21

2 Week Range

Now: $7.20

$2.21

$9.33

Volume

751,493 shs

Average Volume

131,901 shs

Market Capitalization

$90.35 million

P/E Ratio

N/A

Dividend Yield